A carregar...
The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
BACKGROUND: Highly active antiretroviral therapy (HAART) has transformed HIV-1 infection from a deadly disease to a manageable chronic illness, albeit does not provide a cure. The recently developed genome editing system called CRISPR/Cas9 offers a new tool to inactivate the integrated latent HIV-1...
Na minha lista:
| Publicado no: | Retrovirology |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4359768/ https://ncbi.nlm.nih.gov/pubmed/25808449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12977-015-0150-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|